Vabysmo maintained vision improvements with extended treatment intervals up to 4 months for people with retinal vein occlusion in phase III studies: Roche Ruchika Sharma10 Oct 2023 2:30 PM ISTBasel: Roche has announced positive topline long-term results from the global phase III BALATON and COMINO studies, evaluating extended treatment...
Roche presents positive results for spinal muscular atrophy treatment Evrysdi in babies Ruchika Sharma8 Oct 2023 11:00 AM ISTBasel: Roche has presented positive results from the primary analysis of the ongoing RAINBOWFISH study assessing the efficacy and safety of Evrysdi...
Roche open to big acquisitions 'if it makes scientific and financial sense', CEO tells NZZ am Sonntag Ruchika Sharma11 Sept 2023 12:23 PM ISTZurich: Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker...
Phase 2 study of Zilebesiran met primary endpoint: Roche,Alnylam Ruchika Sharma9 Sept 2023 12:38 PM ISTBasel: Roche and Alnylam have announced that the Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed...
Roche Alecensa delivers unprecedented Phase III results for people with ALK positive early stage lung cancer Ruchika Sharma4 Sept 2023 1:30 PM ISTBasel: Roche has announced that the Phase III ALINA study evaluating Alecensa (alectinib), compared with platinum-based chemotherapy, met its primary...
Roche Tecentriq SC approved in Great Britain Ruchika Sharma2 Sept 2023 10:00 AM ISTInjecting Tecentriq subcutaneously (under the skin) takes approximately seven minutes.
Strides Singapore arm bags USFDA nod for Mycophenolate Mofetil for Oral Suspension Ruchika Sharma31 Aug 2023 1:30 PM ISTMycophenolate Mofetil for Oral Suspension belongs to a group of medicines called immunosuppressants.
Roche Evrysdi gets European Commission nod for babies under two months old with spinal muscular atrophy Ruchika Sharma30 Aug 2023 3:00 PM ISTBasel: Roche has announced that the European Commission has approved the extension of the Evrysdi (risdiplam) European Union (EU) marketing...
Roche reports inadvertent disclosure in lung cancer immunotherapy study Ruchika Sharma23 Aug 2023 2:30 PM ISTBasel: Roche announced today that it has been made aware of an inadvertent disclosure of the second interim analysis of the Phase III SKYSCRAPER-01...
Roche gets CDSCO panel nod to study Crovalimab Dr. Divya Colin20 Aug 2023 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Patent infringement: Roche sues Novartis unit over generic lung disease drug Ruchika Sharma3 Aug 2023 1:30 PM ISTSwiss drugmaker Roche's Genentech subsidiary has accused a Novartis unit of infringing one of its patents by selling a generic version of its...
Roche Gets CDSCO Nod To Study Anticancer FDC Drug Dr. Divya Colin25 July 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Roche has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central...
